FIELD: medicine; pharmacology.
SUBSTANCE: suggested use of 2-ethyl-6-methyl-3-oxypiridin succinate as treatment in combination with traditional therapy for faster physical rehabilitation of patients with chronic heart failure.
EFFECT: improved diastolic function of the left myocardial ventricle; higher tolerance to physical stress in patients with chronic cardiac failure of any origin.
2 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF MEDICINAL AGENT MEXICOR (2-ETHYL-6-METHYL-3-OXIPYRIDINE SUCCINATE) FOR ACCELERATED PHYSICAL REHABILITATIONS OF PATIENT SUFFERING FROM MYOCARDIUM HEART ATTACK | 2006 |
|
RU2328284C2 |
METHOD FOR REHABILITATION OF ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASES ACCOMPANIED BY CHRONIC HEART INSUFFICIENCY FOLLOWING MYOCARDIAL INFARCTION | 2014 |
|
RU2554756C1 |
METHOD OF TREATING PATIENTS WITH CHRONIC CARDIAC FAILURE OF ISCHEMIC GENESIS | 2010 |
|
RU2424015C2 |
METHOD OF DIFFERENTIAL PRESCRIPTION OF β-ADRENORECEPTOR BLOCKING AGENTS IN PATIENTS WITH CHRONIC CARDIAC FAILURE | 2010 |
|
RU2454998C1 |
METHOD FOR TREATING CHRONIC HEART FAILURE | 2005 |
|
RU2304964C2 |
METHOD OF TREATING PATIENTS SUFFERING CHRONIC CARDIAC FAILURE COMPROMISED TYPE 2 DIABETES | 2010 |
|
RU2421218C1 |
METHOD FOR PREDICTING CARDIAC INSUFFICIENCY IN CARDIAC ISCHEMIA PATIENTS IN POSTINFARCTION PERIOD | 2004 |
|
RU2269922C1 |
METHOD OF COMPLEX IMMUNOMODULATING TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE | 2010 |
|
RU2428980C1 |
METHOD FOR TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE AND CHRONIC BRAIN ISCHEMIA | 2021 |
|
RU2752065C1 |
METHOD FOR IMPROVING DIASTOLIC FUNCTION OF LEFT VENTRICLE AT INITIAL STAGES OF CARDIOMYOPATHIES IN CHILDREN WITH INSULIN-DEPENDENT DIABETES MELLITUS | 2000 |
|
RU2200019C2 |
Authors
Dates
2008-05-27—Published
2006-04-11—Filed